Philipp Uhl
Impact in
- Microbiology top 2%
- Antimicrobial Peptides and Activities
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
Papers in
- Microbiology 15
- Antimicrobial Peptides and Activities 15
-
- Advanced Drug Delivery Systems 11
- Co-authors
- Walter Mier (32 shared papers)Gert Fricker (17 shared papers)Uwe Haberkorn (11 shared papers)Christian Kleist (10 shared papers)Cornelius Domhan (7 shared papers)Florian Umstätter (9 shared papers)Max Sauter (17 shared papers)Dominik Witzigmann (7 shared papers)
- Journals
- Investigative Ophthalmology & Visual Science (4 papers)Drug Discovery Today (3 papers)Journal of Pharmaceutical and Biomedical Analysis (3 papers)Advanced Therapeutics (3 papers)Nanomedicine Nanotechnology Biology and Medicine (3 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Philipp Uhl
58 papers receiving 986 citations
Peers
Comparison fields: 5 of 107
- Microbiology 203
- Pharmaceutical Science 154
- Molecular Medicine 64
- Biomaterials 113
- Molecular Biology 441
Countries citing papers authored by Philipp Uhl
This map shows the geographic impact of Philipp Uhl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philipp Uhl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philipp Uhl more than expected).
Fields of papers citing papers by Philipp Uhl
This network shows the impact of papers produced by Philipp Uhl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philipp Uhl. The network helps show where Philipp Uhl may publish in the future.
Co-authors
The 25 scholars most cited alongside Philipp Uhl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 117 | |
| 2 | 2020 | 81 | |
| 3 | 2017 | 77 | |
| 4 | 2016 | 71 | |
| 5 | 2019 | 57 | |
| 6 | 2019 | 47 | |
| 7 | 2016 | 39 | |
| 8 | 2014 | 37 | |
| 9 | 2018 | 32 | |
| 10 | 2019 | 29 | |
| 11 | 2014 | 28 | |
| 12 | 2019 | 28 | |
| 13 | 2021 | 27 | |
| 14 | 2024 | 25 | |
| 15 | 2022 | 22 | |
| 16 | 2020 | 22 | |
| 17 | 2020 | 20 | |
| 18 | 2019 | 15 | |
| 19 | 2018 | 15 | |
| 20 | 2022 | 13 |
About Philipp Uhl
Philipp Uhl is a scholar working on Microbiology, Pharmaceutical Science, Radiology, Nuclear Medicine and Imaging, Molecular Medicine and Molecular Biology, having authored 66 papers that have together received 1.0k indexed citations. Recurring topics across this work include Antimicrobial Peptides and Activities (15 papers), RNA Interference and Gene Delivery (13 papers), Advanced Drug Delivery Systems (11 papers), Retinal and Macular Surgery (9 papers), Antibiotic Resistance in Bacteria (6 papers), Antimicrobial Resistance in Staphylococcus (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Hepatitis B Virus Studies (4 papers). The work is most often cited by research in Microbiology (203 citations), Pharmaceutical Science (154 citations), Molecular Medicine (64 citations), Biomaterials (113 citations) and Molecular Biology (441 citations). Philipp Uhl has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Walter Mier, Gert Fricker, Uwe Haberkorn, Christian Kleist, Cornelius Domhan, Florian Umstätter, Max Sauter, Dominik Witzigmann, Stefan Zimmermann and Karin Leotta. Their work appears in journals such as Investigative Ophthalmology & Visual Science, Drug Discovery Today, Journal of Pharmaceutical and Biomedical Analysis, Advanced Therapeutics and Nanomedicine Nanotechnology Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.